1. Home
  2. IAF vs RCEL Comparison

IAF vs RCEL Comparison

Compare IAF & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Australia Equity Fund Inc.

IAF

abrdn Australia Equity Fund Inc.

HOLD

Current Price

$12.30

Market Cap

129.2M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.00

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IAF
RCEL
Founded
1985
N/A
Country
United States
United States
Employees
N/A
226
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.2M
132.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IAF
RCEL
Price
$12.30
$4.00
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
54.8K
171.8K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
11.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.73
$3.22
52 Week High
$14.54
$10.28

Technical Indicators

Market Signals
Indicator
IAF
RCEL
Relative Strength Index (RSI) 55.71 46.60
Support Level $12.72 $3.36
Resistance Level $13.19 $4.09
Average True Range (ATR) 0.23 0.22
MACD 0.11 -0.00
Stochastic Oscillator 98.58 63.89

Price Performance

Historical Comparison
IAF
RCEL

About IAF abrdn Australia Equity Fund Inc.

Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: